The Impact of Thoracic Radiotherapy on Advanced Small Cell Lung Cancer in the Context of Immunotherapy: A Review of Existing Evidence - Top-Institutions - MDSpire

The Impact of Thoracic Radiotherapy on Advanced Small Cell Lung Cancer in the Context of Immunotherapy: A Review of Existing Evidence

  • By

  • Zhipeng Li

  • Xiao Lei

  • Xingdong Guo

  • Qiduo He

  • Yanan Han

  • Pei Zhang

  • Lehui Du

  • Baolin Qu

  • April 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Thoracic Oncology
    • Radiation Oncology
    • Immunotherapy

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Thoracic Oncology
    • Radiation Oncology
    • Immunotherapy

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Thoracic Oncology
    • Immunotherapy

  • #4

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

    Baltimore, MD

    Key Differentiators

    • Thoracic Oncology
    • Radiation Oncology
    • Immunotherapy

  • #5

    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center
    University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

    San Francisco, CA

    Key Differentiators

    • Thoracic Oncology
    • Radiation Oncology
    • Immunotherapy

Original Source(s)

The Impact of Thoracic Radiotherapy on Advanced Small Cell Lung Cancer in the Context of Immunotherapy: A Review of Existing Evidence

  • by Zhipeng Li, Xiao Lei, Xingdong Guo, Qiduo He, Yanan Han, Pei Zhang, Lehui Du, Baolin Qu

  • April 29, 2026

Related Content

Management of toxicities from antibody – drug conjugates in breast cancer

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report